Login

Balance Sheets

In millions of USD, except per-share amounts
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
ASSETS
Current assets
Cash
Deferred offering costs
Prepaid expenses
Prepaid income taxes
Total current assets
Investments held in Trust Account
TOTAL ASSETS
LIABILITIES, CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS’ DEFICIT
Current liabilities
Accrued expenses
Accrued offering costs
Promissory note – related party
Due to shareholders
Income taxes payable
Total current liabilities
Deferred underwriting fee payable
Warrant liabilities
Warrant liabilities
TOTAL LIABILITIES
Class A common stock subject to possible redemption, 15,000,000 shares at $10.00 per share as of March 31, 2022 and December 31, 2021
Class A common stock subject to possible redemption, 4,046,842 shares at approximately $10.15 per share and $10.08 per share as of March 31, 2023 and December 31, 2022, respectively
STOCKHOLDERS’ DEFICIT
Class A common stock, $0.0001 par value; 100,000,000 shares authorized; 550,000 shares issued and outstanding (excluding 4,046,842 shares subject to possible redemption) as of March 31, 2023 and December 31, 2022, respectively
Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 3,887,500 shares issued and outstanding as of March 31, 2023 and December 31, 2022
Additional paid-in capital
Accumulated deficit
TOTAL STOCKHOLDERS’ DEFICIT
TOTAL LIABILITIES, CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS’ DEFICIT

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support